(Q44201118)

English

Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir

scientific article published in November 2002

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Chronic erosive herpes simplex virus infection of the penis in a human immunodeficiency virus-positive man, treated with imiquimod and famciclovir (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

A G Danielsen

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

C S Petersen

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

J Iversen

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

147

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1034-1036

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Relation between herpes simplex viruses and human immunodeficiency virus infections

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

The imidazoquinolines, imiquimod and R-848, induce functional, but not phenotypic, maturation of human epidermal Langerhans' cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

Imiquimod, a topical immune response modifier, induces migration of Langerhans cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.504412.X

21 January 2018

Identifiers

10.1046/J.1365-2133.2002.504412.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44201118&oldid=2108473066"